CorVel Corporation
CRVL
#3669
Rank
A$5.47 B
Marketcap
A$108.47
Share price
1.00%
Change (1 day)
-2.38%
Change (1 year)
Text size:
1

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

--------------

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934

FOR THE FISCAL YEAR ENDED MARCH 31, 2001

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934

FOR THE TRANSITION PERIOD FROM TO
-------------------- ----------------------

COMMISSION FILE NUMBER 0-19291

CORVEL CORPORATION
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

------------------


DELAWARE 33-0282651
(STATE OR OTHER JURISDICTION OF (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION) IDENTIFICATION NUMBER)

2010 MAIN STREET, SUITE 1020, IRVINE, CALIFORNIA 92614
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)


REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (949) 851-1473

-------------------

SECURITIES REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT: NONE
SECURITIES REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT: COMMON STOCK

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

YES NO
----- -----

Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of Registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [X]

As of May 31, 2001, there were approximately 7,446,000 shares of Common
Stock outstanding.
2

The Registrant does not have different classes of Common Stock and as of
May 31, 2001, the aggregate market value of the Common Stock of the Registrant
held by non-affiliates was approximately $161,000,000, based upon the closing
sale price of such stock on that date. For purposes of such calculation, only
executive officers, board members, and beneficial owners of more than 10% of the
Company's outstanding Common Stock are deemed to be affiliates.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Registrant's Definitive Proxy Statement for the Annual
Meeting of Stockholders to be held on or about August 2, 2001, as filed with the
Commission pursuant to Regulation 14A, are incorporated by reference in Part III
of this Report.

Portions of the Registration Statement filed with the Commission on Form
S-1 (SEC File No. 33-40629), the Company's Annual Reports on Form 10-K for the
fiscal years ended March 31, 1995, March 31, 1994, March 31, 1993 and March 31,
1992, and the Company's filing on Form 8-K on February 28, 1997, are
incorporated by reference in Part IV of this Report.

The Private Securities Litigation Reform Act of 1995 provides a "safe
harbor" for forward-looking statements. This Annual Report contains
forward-looking statements within the meaning of the Securities Act of 1933 and
the Securities Exchange Act of 1934. The Company's actual results could differ
materially from those projected in the forward-looking statements as a result of
the factors described under "Cautionary Statement Regarding Forward-Looking
Statements" and elsewhere in this Annual Report. Investors in the Company's
securities should consider these factors.
3

CORVEL CORPORATION

2001 FORM 10-K ANNUAL REPORT

TABLE OF CONTENTS

Page
----
PART I

Item 1. Business 1

Item 2. Properties 20

Item 3. Legal Proceedings 20

Item 4. Submission of Matters to a Vote of Security Holders 20

PART II

Item 5. Market for the Registrant's Common Equity and Related
Stockholder Matters 21

Item 6. Selected Financial Data 21

Item 7. Management's Discussion and Analysis of Financial Condition
and Results of Operations 21

Item 7a. Quantitative and Qualitative Disclosures About Market Risk 21

Item 8. Financial Statements and Supplementary Data 22

Item 9. Changes in and Disagreements with Accountants on Accounting
and Financial Disclosure 22

PART III

Item 10. Directors and Executive Officers of the Registrant 22

Item 11. Executive Compensation 22

Item 12. Security Ownership of Certain Beneficial Owners and Management 22

Item 13. Certain Relationships and Related Transactions 22

PART IV

Item 14. Exhibits, Financial Statement Schedules and Reports on Form 8-K 23
4

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This Report includes "forward-looking statements" including, in
particular, the statements about our plans, strategies and prospects under the
headings Item 1. "Business," including "Risk Factors" and Item 7. "Management's
Discussion and Analysis of Financial Condition and Results of Operations."
Although we believe that these forward-looking statements reasonably reflect our
plans, intentions and expectations, we can give no assurance that we will
achieve these plans, intentions or expectations. Certain important factors that
could cause actual results to differ materially from the forward-looking
statements we make in this report. Representative examples of these factors
include (without limitation):

- general industry and economic conditions; cost of capital and
capital requirements;

- competition from other managed care companies;

- the ability to expand certain areas of the Company's business;

- shifts in customer demands; the ability of the Company to produce
market-competitive software;

- changes in operating expenses including employee wages, benefits and
medical inflation;

- changes in regulations affecting the workers' compensation,
insurance and healthcare industries in general,

- dependence on key personnel;

- possible litigation and legal liability in the course of operations;

- and the continued availability of financing in the amounts and at
the terms necessary to support the Company's future business.

These factors and the risk factors described in "Management's Discussion
and Analysis of Financial Condition and Results of Operations" are not
necessarily all of the important factors that could cause actual results to
differ materially from those expressed in any of our forward-looking statements.
Other unknown or unpredictable factors also could have material adverse effects
on our future results. The forward-looking statements included in this annual
report on Form 10-K are made only as of the date of this annual report. We
expressly disclaim any intent or obligation to update any forward-looking
statements to reflect subsequent events or circumstances.

PART I

ITEM 1. BUSINESS.

INTRODUCTION

CorVel Corporation ("CorVel" or the "Company") is an independent
nationwide provider of managed care services designed to address the escalating
medical costs of workers' compensation and other healthcare benefits, primarily
coverage under group health and auto policies. The Company's services include
automated medical fee


1
5

auditing, preferred provider networks, utilization review, medical case
management, vocational rehabilitation services, early intervention, and
independent medical examinations. Such services are provided to insurance
companies, government entities, third-party administrators ("TPAs"), and
self-administered employers to assist them in managing the medical costs and
monitoring the quality of care associated with healthcare claims.

The Company, which is a Delaware corporation, has its principal
executive offices located at 2010 Main Street, Suite 1020, Irvine, California,
92614. The Company's telephone number is 949-851-1473.

RECENT DEVELOPMENTS

During fiscal 2001, the Company introduced its CareMC marketsite
(http://www.caremc.com). Care(MC) serves the healthcare and claims needs of
insurers and employers managing employee absences and disability insurance
losses. Care(MC) includes a website which provides for direct access to CorVel
Corporation's managed care services and is also designed to function as an
application service provider (ASP) through which other managed care providers
will supply their services to major employers and insurers nationwide.

Care(MC) was developed in response to requests from major insurers to
open access for their various managed care vendors to CorVel's line of ASP
services. Other features of the website include electronic communications among
providers, payors, employers, managed care vendors and patients; service
scheduling; purchase transactions; automated provider reimbursement adjudication
and vendor billing and collections.

Care(MC) offers a suite of online services, and solutions that unite
multiple managed care professionals real time, and on a single website, creates
a seamless, unified process for claims. This suite of solutions for managed care
professionals includes:

Referral Basket: Referral Basket provides access to multiple managed
care professionals, suppliers, and organizations. Claims professionals can
expedite case referrals and requests for service, eliminating paperwork through
the use of a single, on-going electronic file. Referrals are sent to the
preferred managed care provider and confirmed as received in real time.

Claims Center: Claims Center helps claims professionals organize and
streamline their files. Using the power of the internet, claims professionals
can access comprehensive sets of information on open, closed or pending claims
from multiple managed care providers. Through the CareMC Claims Center, the
claims professional can interact with multiple managed care providers in real
time, access and relay claims progress updates in real time, sort and search
comprehensive claims data, and maintain a single, secure, electronic case file
throughout the life of a claim.


2
6

Bill Review: Care(MC) Bill Review assures accuracy, accountability and
timeliness by tracking costs from the time a claim begins until it is closed.
Care(MC) bill review is founded on proprietary software, artificial
intelligence, the integration of information from multiple resources, and
instant access to information. With CareMC Bill Review, the claims professionals
can record bill and cost data in real time, access bill review status instantly,
review and analyze in-patient and out-patient bills, and authorize payments
on-line based on fee schedules and preferred provider ("PPO") agreements.

Reporting Center: Reporting Center adds value by collecting a myriad of
critical details from multiple sources, then organizing and delivering that
information in real time. Care(MC) helps claims professionals by sorting,
simplifying and formatting comprehensive case data. Reports can be tailored to
highlight individual critical cases or summarized to highlight priority trends.
Through the Care(MC) Reporting Center, claims professionals can view timely
status reports and cost updates, use artificial intelligence to flag priority
issues, tailor reports to highlight urgent cases or summarize important trends,
and perform cost and savings analyses using an advanced and integrated database.

The Care(MC) suite of solutions for employers includes:

Absence Manager: Absence Manager offers employers a single worksite for
the reporting of all absences. Workers' compensation, short-term disability and
Family Medical Leave Act ("FMLA") absences are all integrated in one patient
management process. Care(MC) documents up-to-the-minute employee absences,
expedites compliance with government and insurer reporting requirements, and can
individualized case management activities to follow a specified preference.

Disability Manager: Disability Manager gives employers a comprehensive
overview of short-term disability and workers' compensation exposures, as well
as the details of each lost-time case. Through Disability Manager, employers can
express their preferences regarding the administration of their benefit program,
and track the progress and status of disability claims.

Employment Services: Employment Services helps administer a wide range
of medical evaluation strategic to the employment process for work groups
susceptible to higher rates of injury or absence. Care(MC) expedites requests
for service and coordinates the scheduling of appointments using an efficient,
easy-to-use website. Employers can monitor the status of scheduled activities
online and in real time, using the services provided. They can reduce the cost
and complexity of conducting physicals, fitness for duty testing or other
evaluations.

Reporting Center: The Care(MC) Reporting Center provides real time
access to the status of the employer's benefit management program. The employer
can be informed daily regarding summarized information, as well as trends and
analytic perspectives. Such information is especially useful in understanding
the underlying causes of medical issues and unexpected outcomes, so the employer
can react to emerging problems immediately.


3
7

CURRENT YEAR DEVELOPMENT - BOARD AUTHORIZES INCREASE IN STOCK REPURCHASE PROGRAM

During fiscal 2001, the Company announced that its Board of Directors
had approved a 1,000,000 share expansion to its existing stock repurchase plan.
Including this expansion, the total number of shares authorized to repurchase
has now been increased to 3,400,000 shares. Since commencing this program in the
fall of 1996, the Company has repurchased approximately 2,808,000 common shares
through March 31, 2001, equal to 27% of its outstanding stock at a cost of
approximately $54 million. These repurchases were funded from the Company's
operating earnings and have reduced the Company's current common shares
outstanding to 7,489,000 shares.

INDUSTRY OVERVIEW

Workers' compensation is a federally-mandated, state-legislated,
comprehensive insurance program that requires employers to fund medical
expenses, lost wages and other costs resulting from work-related injuries and
illnesses. Since their introduction in the early 1900's, these programs have
been expanded to all fifty states and the District of Columbia. Each state is
responsible for implementing and regulating its own program. Consequently,
workers' compensation benefits and arrangements vary on a state-by-state basis
and are often highly complex.

Workers' compensation plans generally require employers to fund all of
an employee's costs of medical treatment and a significant portion of lost
wages, legal fees and other associated costs. Typically, work-related injuries
are broadly defined, and injured or ill employees are entitled to extensive
benefits. Employers are required to provide first-dollar coverage with no
co-payment or deductible due from the injured or ill employee for medical
treatment and, in many states, there is no lifetime limit on expenses. However,
in exchange for providing this coverage for employees, employers are not subject
to litigation by employees for benefits in excess of those provided by the
relevant state statute. In most states, the extensive benefits coverage (for
both medical costs and lost wages) is provided through the purchase of
commercial insurance from private insurance companies, participation in
state-run insurance funds or employer self-insurance.

Provider reimbursement methods vary on a state-by-state basis. A
majority of states have adopted fee schedules pursuant to which all health care
providers are uniformly reimbursed. The fee schedules are set by each state and
generally prescribe the maximum amounts that may be reimbursed for a designated
procedure. In states without fee schedules, health care providers are reimbursed
based on usual customary and reasonable fees charged in the particular state in
which the services are provided.

Workers' compensation is a statutorily defined employee benefit, which
varies on a state-by-state basis. Workers' compensation laws generally require
employers to fully pay for employees' costs of medical treatment, lost wages,
legal fees and other costs


4
8

associated with work-related injuries and disabilities and, in certain
jurisdictions, mandatory vocational rehabilitation. Companies provide such
coverage to their employees through either the purchase of commercial insurance
from private insurance companies, participation in state-run funds or through
self-insurance.

Many states do not permit employers to restrict a claimant's choice of
provider, making it more difficult for employers to utilize managed care
approaches such as HMO's and PPO's. However, in many states, employers have the
right to direct employees to a specific primary healthcare provider during the
onset of a workers' compensation case, subject to the right of the employee to
change physicians after a specific period. Since workers' compensation benefits
are mandated by law and are subject to extensive regulation, payors and
employers do not have the same flexibility to alter benefits as they have with
other health benefits programs. In addition, workers' compensation programs vary
from state to state, making it difficult for payors and multi-state employers to
adopt uniform policies to administer, manage, and control the costs of benefits.
As a result, managing the cost of workers' compensation requires approaches,
which are tailored to the specified regulatory environment(s) in which the
employer is operating.

Managed care techniques are intended to control the cost of healthcare
services and to measure the performance of providers through intervention and
on-going review of services proposed and actually provided. Managed care
techniques were originally developed to stem the rising costs of group medical
care. Historically, employers were slow to apply managed care techniques to
workers' compensation costs primarily because the aggregate costs are relatively
small compared to costs associated with group health benefits and because
state-by-state regulations related to workers' compensation are far more complex
than those related to group health. However, in recent years, employers and
insurance carriers have been increasing their focus on applying managed care
techniques to control their worker's compensation costs.

An increasing number of states have adopted legislation encouraging the
use of workers' compensation managed care organizations ("MCO's") in an effort
to allow employers to control their workers' compensation costs. MCO laws
generally provide employers an opportunity to channel injured employees into
provider networks. In certain states, MCO laws require licensed MCO's to offer
certain specified services, such as utilization management, case management,
peer review and provider bill review. Most of the MCO laws adopted to date
establish a framework within which a company such as the Company can provide its
customers a full range of managed care services for greater cost control.

Auto Managed Care and Group Health Managed Care

Medical expenses are one of the largest components of auto insurers'
costs and ultimately drive the premiums charged to policyholders. Effective
management of these costs, combined with an optimal managed care program, is the
key to reducing costs and achieving customer satisfaction. The Company's Auto
Managed Care Program offers a continuum of services that facilitate patient
recovery and medical costs containment.


5
9

The Company's Group Health Program also includes a continuum of services
designed to control healthcare expenditures while advocating quality care for
employees. Employee health benefit programs demand broad, flexible provider
choice with assisted access to the healthcare system.

BUSINESS STRATEGY

The Company believes that payors and employers impacted by the
escalating medical costs of workers' compensation, group health, and auto
insurance will increasingly require services and programs to manage such costs.
The Company's business strategy is to offer a range of services through a
national network of branch offices, supported by information management systems,
to respond to such need on both a local and national level.

Breadth of Service

A key element of the Company's strategy is to capitalize on its
background and specialization in workers' compensation, established initially in
the area of case management, to offer a range of services, including bill
review, PPO's and independent medical examinations ("IME's"), to assist
insurance carriers, TPA's and self-administered employers in managing the cost
of workers' compensation and monitoring the quality of care provided. The
Company plans to continue to expand its range of services to respond to the
needs of its customers.

National Branch Office Network

An integral part of the Company's strategy is to offer services at the
local or regional level where workers' compensation claims are administered.
Each office has access to centralized services and software developed at the
Company's corporate offices and is capable of responding to the particular
regulatory environment in which it operates. The Company adds branch offices by
identifying target markets, generally geographically contiguous to an existing
market, where it believes it can successfully introduce one or more of its
services. The Company may also establish new offices in response to the needs of
national customers. In addition to expanding the number of branch office
locations, the Company expects to add existing services as well as new services
to its branch offices.

Informational Management Capabilities

The Company's strategy also includes the continued development of
software and its computer system network capable of supporting the review and
management of medical information on the internet. Claims and patient data can
be entered from field locations, processed by the Company and made available for
consolidated reporting or for automated interfacing to customer computer
systems.


6
10

BUSINESS

The Company offers services in two general categories, provider programs
and patient management services, to assist its customers in managing the
increasing medical costs of workers' compensation, group health and auto
insurance, and monitoring the quality of care provided to claimants.

PROVIDER PROGRAMS

The Company's provider program services are designed to reduce the price
paid by its customers for medical services rendered in workers' compensation
cases. The provider programs offered by the Company include automated medical
fee auditing, preferred provider services, and retrospective utilization review.

MedCheck - CorVel's Proprietary Bill Review System

Many states have adopted fee schedules, which regulate the maximum
allowable fees payable under workers' compensation for procedures performed by a
variety of health treatment providers. Such schedules may also include fees for
hospital treatment. The purpose of a fee schedule is to standardize the billing
process by using uniform procedure descriptions and to set maximum reimbursement
levels for each covered service.

Certain other states permit payors to pay workers' compensation medical
costs limited to usual and customary charges for the relevant community. The
Company provides automated medical fee auditing to assist the Company's
customers in verifying that the fees charged by workers' compensation health
care providers comply with state fee schedules, or are consistent with usual and
customary charges.

The Company offers its fee schedule auditing through a computerized
medical bill review service called MedCheck, which combines automated data
reporting and transmission capabilities. MedCheck consists of an online
computer-based information system comprised of a proprietary software program
which stores and accesses state-mandated fee schedules and licensed usual and
customary charge information. MedCheck is also being utilized for the review of
medical charges under certain non-workers' compensation insurance coverages.
With the MedCheck service, the Company is capable of:

o Checking for provider charges which exceed charges allowable under
fee schedules or usual and customary charges, in accordance with the
requirements of the relevant jurisdiction

o Repricing provider bills to contractual PPO reimbursement levels

o Checking for duplicate billing

o Checking for billed services or procedures that are excessive,
unnecessary or unrelated to treating the particular medical problem


7
11

o Checking for "unbundled" billings where the medical services
performed are billed in components, resulting in higher total charges
than would be the case if the services were billed in the aggregate

o Engaging in on site processing of claims

o Sending claims data directly to carriers' databases, thereby reducing
costs due to repetitive or erroneous data entry

o PPO management

o Internet based reporting tools

o Pharmacy review

In addition to providing the MedCheck software suite, CorVel also
supports insurers and administrators with a full array of outsource
capabilities. The Company provides a proprietary national PPO, as well as case
managers both on-site and from telephonic hub operations. These systems can be
interfaced to insurers through the Company's wide area network (WAN) as well as
through its website and virtual private networks (VPN's). When installed at an
insurer, the MedCheck suite can accept electronic data interfaces (EDI) from
CorVel and other sources. This interface automates the reimbursement of provider
reimbursements, allows for the application of all MedCheck fees to the
individual claim file and eliminates the need for manual redundant data entry of
MedCheck results by the carriers' claims personnel. In addition, MedCheck can
send its own files on to the mainframe claims administration systems of major
insurers and other payors. The system is designed for easy access by claims
adjusters and includes functionality for such part-time users within the claims
payment environment.

Recent MedCheck Development

During fiscal 2001, the Company announced the release of its MedCheck,
version 3.5 software, which adjudicates medical reimbursement for workers'
compensation, automobile, and group health claims. Casualty claims are typically
managed through many geographically dispersed offices. MedCheck, version 3.5, is
web-enabled, allowing claims to be submitted electronically, as well as through
traditional paper processes. Version 3.5, includes expanded PPO administration
features and browser-based interfaces for both claims processing and reporting.
The product had been previously expanded to include features unique to the
processing of automobile claims. The current release is focused on applications
in the workers' compensation market, and is of particular interest to State
Funds, municipalities and other large insurance and TPA payors.

CorVel customers can utilize MedCheck's service bureau capabilities to
outsource their bill review processing needs. However, they can also process
varying portions of their workload from their own sites, or utilize MedCheck on
an ASP basis. In this latter mode the claims administration organization can
access the software over the Internet and process all, or a portion of their
claims, themselves. The use of ASP processing allows payors to benefit from all
of MedCheck's capabilities without having to invest in computer systems,
software support, and maintenance or the administration of the many information
databases critical to proper medical reimbursement adjudication.


8
12

MedCheck includes automated processing capabilities. CorVel's AI module
("First Review") is designed to evaluate incoming medical bills, apply medical
protocols and reimbursement guidelines and complete the reimbursement of the
medical professional, all automatically. MedCheck 2000 is architected so that
customers can seamlessly blend outsourced processing with work performed
internally. Claims professionals, as well as various levels of management can
easily access real-time reports of claims history. In addition to these AI
features, MedCheck's development reflects CorVel's experience as one of the
leading managed care companies in the country. The Company plans to continue to
invest in the expansion of its MedCheck medical review software to better serve
the claims processing needs of customers through automated interfacing with its
customers' computer systems.

Preferred Provider Services

PPO's are groups of hospitals, physicians and other health care
providers that offer services at pre-negotiated rates to employee groups. PPO
networks offer the employer an additional means of managing workers'
compensation costs by reducing the per-unit price of medical services provided
to employees. The Company provides its customers with access to its PPO network,
"CorCare". Bills submitted from PPO's are identified through the MedCheck review
process, and the submitted charges are then audited against the PPO schedule and
against any applicable fee schedule or usual and customary charges. The fee
approved for payment is the lower of the submitted charges or the lowest
allowable fee identified. Some of the features of the Company's PPO network
services include: national networks for all coverages, board certified
physicians, automated provider credentialing, patient channeling, online
provider look-up and printable directories.

The Company offers online provider look-up on its website
(http://www.corvel.com) or the Company's eCommerce website
(http://www.caremc.com) where users can locate providers in their area, see a
map, get door to door driving directions or print an entire directory. CorVel
also offers 24 hour, toll free telephonic access via its Interactive Voice
Response (IVR) System.

Hospital Inpatient and Outpatient Bill Review Services

The Company expanded its line of bill review services by adding unique
capabilities for reviewing hospital inpatient and outpatient medical
reimbursement. CorVel offers cost containment by applying a clinical medical
review to hospital claims conducted by registered nurses. Our nurse reviewers
use a proprietary nationwide database of usual and customary charges. This
database provides usual and customary charges for the detailed charges, which
are specified on the itemized hospital bill. Access to hospital charge master
line items through this database enables CorVel to track billing trends
throughout the nation, while streamlining the nurse review process. This
service, named MedCheck Select, provides a national database of hospital charges
detailed by line item in each hospital's individual billing system. By
converting different hospital billing systems to a common database, the Company
can create "usual and customary" expectations for hospital expenses. Revenues
for this service expanded throughout the


9
13

year, and add to the Company's line of in-patient medical review and PPO
activities. Some of the features of this service include: hospital line item
bill review, fee negotiation, application of PPO contracts, and usual &
customary review.

Objectives of the service include:

o Assure that billed charges are usual and customary

o Confirm services were medically necessary

o Reduce claim costs through negotiated agreements

o Substantiate, by report, charges over usual and customary

o Support the payor and patient in all appeals

Check Processing

CorVel has the capability to provide checkwriting services for its
customers. The provider payment check can be added to the bill analysis (EOB) to
produce one combined document, which is mailed to the provider.

Utilization Management

Utilization Management programs preview proposed ambulatory care to
determine: appropriateness, frequency, duration, and setting. Utilizing
experienced RN's, proprietary medical treatment protocols, and "expert systems"
technology, unnecessary treatments and associated costs are avoided. Processes
in Utilization Management include: review injury, diagnosis, and treatment plan;
contact and negotiate provider's treatment requirements, certifying
appropriateness of treatment parameters and/or additional treatment requests;
and respond to provider requests for additional treatment.

Precertification of Hospitalization

The pre-admission certification program is a review service, which
verifies the medical necessity of proposed hospital admissions, and determines
the appropriate length of stay. The CorVel staff of nurses and reviewers,
assisted by an automated medical rules/protocols system and backed up by
physician consultants, individually evaluates every hospital admissions request.
Pre-certification objectives include the following: determine appropriateness of
proposed or emergent hospitalization; determine the medical necessity for
hospital admission/inpatient care: explore alternatives to inpatient treatment;
if inpatient care is required, determine the appropriate length of stay and
monitor the patient's condition throughout the hospitalization to prevent
unnecessary inpatient days; channel the patient to a CorVel PPO
provider/facility; and develop and implement a timely discharge plan.

Inpatient Utilization Review

The Company offers pre-certification and concurrent utilization review
services. The Company's pre-certification service is designed to be utilized
prior to the injured employee's admission to the hospital. Upon notification by
a claims manager or


10
14

employer, a Company nurse reviews the appropriateness of the proposed plan of
care, the need for inpatient hospitalization, and the appropriate length of
stay. Under the Company's concurrent review service the nurse reviewers monitor
the medical necessity and appropriateness of the patient's continued
hospitalization through regular contact with the hospital and the patient's
physician and may identify cases that lend themselves to alternate treatment
settings or home care.

PATIENT MANAGEMENT SERVICES

In addition to its provider program services, the Company offers a range
of patient management services, which involve working on a one-on-one basis with
injured employees and their various health care professionals, employers and
insurance company adjusters. Patient management services are designed both to
assist in maximizing medical improvement and, where appropriate, to expedite
return to work. The services designed to monitor the medical necessity and
appropriateness of health care services provided to workers' compensation
claimants and to expedite their return to work. The Company offers these
services on a stand-alone basis, or as an integrated component of its medical
cost containment services.

During fiscal 2000, the Company announced the release of version 4.8 of
its Advocacy suite of case management software. This version of Advocacy is
designed to assist employers; insurers, TPA's and case management companies with
the administration of managed care for disability patients. The software is
available for licensure and is supported by CorVel's national network of offices
and managed care professionals.

Advocacy software is CorVel's line of case management tools for the
managed care industry. The Advocacy suite of services include: first notice of
loss, early intervention, utilization management, telephonic case management,
on-site case management, independent medical examinations, peer review and
vocational rehabilitation.

The software helps operators determine available indemnity payments from
the employer and coordinate case management information and issues. Protocols
regarding length of disability are incorporated to guide the management of
cases. Management and operations reports, electronic data interchange and
billing are additional features of the software.

Medical Case Management

The Company offers medical case management services where the injury is
catastrophic or complex in nature, or where prolonged recovery is anticipated.
The medical management components of CorVel's program focuses on medical
intervention, management and appropriateness. In these cases, the Company's case
managers confer with the attending physician, other providers, the patient and
the patient's family to identify the appropriate rehabilitative treatment and
most cost-effective health care


11
15

alternatives, including transferring the patient from a hospital to an
alternative care facility. The program is geared towards offering the injured
party prompt access to appropriate medical providers who will provide quality
cost-effective medical care within the guidelines established and accepted
within the medical community. Case managers may coordinate the services or care
required and may arrange for special pricing of the required services.

Early Telephonic Case Management

Through the claims interface and artificial intelligence process and/or
call center, the need for Medical Case Management is defined. Case Management
facilitates and promotes patient care, which minimizes fragmentation,
facilitates patient progression through the healthcare system, attends to the
needs of the patient, and represents a merging of clinical and financial
interests, systems, and outcomes. The Case Manager, through contact with the
patient and/or family, personalizes an often impersonal healthcare system,
transmits the insurer's concern for the patient, and facilitates communication
between the patient, insurer, and healthcare providers.

Vocational Rehabilitation

In certain states, vocational rehabilitation is a legislated benefit of
workers' compensation, which assists the employee's return to former employment
or another job function with similar economic value. The Company offers
vocational services to reduce workers' compensation costs and expedite the
injured employee's return to work.

CorVel offers vocational services to evaluate the claimant's education,
training, and experience. Vocational services include work capacity assessments,
job analysis, transferable skill analysis, job modification, vocational testing,
job placement assistance, labor market surveys and retraining. After an employee
sustains an injury, the Company performs an analysis of the employee's current
job and other potential jobs which could be performed for the employer, meets
with the treating physician to determine the diagnosis and prognosis for return
to work, presents job analyses to obtain a release to return to work, develops
plans for employee training and generally monitors the employee's return to
work. By working with the employer, they can provide job modification or
light-duty alternatives until the physician lifts the claimant's physical
limitations. In addition, CorVel can evaluate participial payment claims if the
claimant returns to work in a new position, working for less than their
pre-injury wage.

Early Intervention

The earlier the Company becomes involved in an episode of care, the
greater the impact on the healthcare outcome. The Company's early intervention
program begins a series of steps that promote an employee's timely
return-to-work including immediate telephonic assessment to ensure that an
appropriate course of treatment is established and adhered to through the entire
episode of care. CorVel's early intervention program features: automated,
immediate notification, immediate patient assessment, clinical protocols and
guidelines, channeling to preferred providers, private labeling options, and
telephonic case management.


12
16

Independent Medical Examinations

The Company arranges for an IME to assist customers in evaluating
workers' compensation and other casualty claims. A medical examination involves
the assessment of a person's condition often for use in determining the extent
and nature of an injury. IME's are focused to answer specific requirements
including relationships of diagnosis to specific injury, accident or illness,
further treatment recommendations, extent of permanent impairment or disability,
and other information as needed. In general, a physician examines the patient
and prepares a report that describes the nature and extent of injuries, as well
as the future medical requirements. The Company produces preliminary reports
within five days, and final reports within ten days of examination. The Company
provides IMEs through a network of independent physicians. The IME services
include IME's, Second Opinions, Peer Reviews, Chart Reviews, Legal Testimony,
Physical Capacity Exams, Pre-employment Physicials, and Fitness for Duty Exams.

Durable Medical Equipment Network

CorCare DME (durable medical equipment) provides, through CorVel's
eCommerce CareMC, a fully automated equipment ordering and status management
system. Orders are fulfilled using local, preferred equipment distributors and
billing and reimbursement for each transaction is automatically processed.
CorCare DME offers: web-based ordering, call center convenience, preferred
pricing, status management through CareMC, and automated billing and
reimbursement.

CUSTOMERS AND MARKETING

The Company's customers are workers' compensation insurers and, to a
lesser extent, TPA's and self-administered employers. Many claims management
decisions in workers' compensation are the responsibility of the local claims
office of national or regional insurers. The Company's national branch office
network has been established to enable the Company to market and offer its
services at both a local and national account level. The Company is placing
increasing emphasis on national account marketing. The marketing activities of
the Company are conducted by account executives located in key geographic areas,
and by national account executives from the corporate office. Most of the major
workers' compensation insurance carriers conduct business with the Company. None
of the Company's customers represented more than 10% of revenues in fiscal 1999,
2000, or 2001.


13
17

COMPETITION AND MARKET CONDITIONS

The healthcare cost containment industry is highly fragmented and
competitive. The intensity of competition can be expected to increase. The
Company's primary competitors in the workers' compensation market are several
large insurance carriers which offer one or more services similar to those
offered by the Company, HMOs and numerous independent companies, typically on a
local or regional basis. The Company also competes with national and local firms
specializing in utilization review and with major insurance carriers and TPAs
which have implemented their own internal utilization review services. Many of
the Company's competitors are significantly larger and have greater financial
and marketing resources than the Company. There can be no assurance that the
Company will continue to maintain its existing performance, or be successful
with any new products or in any new geographical markets it may enter. Moreover,
the Company's customers may establish the in-house capability of performing
services offered by the Company.

Legislative reforms in some states permit employers to designate health
plans such as HMOs and PPOs to cover workers' compensation claimants. Because
many health plans have the capacity to manage health care for workers'
compensation claimants, such legislation may intensify competition in the market
served by the Company. Within the past few years, several states have
experienced decreases in the number of workers' compensation claims and the
average cost per claim which have been reflected in workers' compensation
insurance premium rate reductions in those states.

The Company believes that declines in workers' compensation costs in
these states are due principally to intensified efforts by payors to manage and
control claim costs, to improved risk management by employers and to legislative
reforms. If declines in workers' compensation costs occur in many states and
persist over the long-term, they may have an adverse impact on the Company's
business and results of operations.

The Company competes on the basis of its specialization in workers'
compensation, breadth of services, ability to offer local services on a
nationwide basis, information management systems and independence from insurance
carriers.

GOVERNMENT REGULATION

General

Managed health care programs for workers' compensation are subject to
various laws and regulations. Both the nature and degree of applicable
government regulation vary greatly depending upon the specific activities
involved. Generally, parties that actually provide or arrange for the provision
of health care services, assume financial risk related to the provision of those
services, or undertake direct responsibility for making payment or payment
decisions for those services, are subject to a number of complex regulatory
schemes that govern many aspects of their conduct and operations.

In contrast, the management and information services provided by the
Company to its customers typically have not been the subject of regulation by
the federal government or the states. Since the managed health care field is a
rapidly expanding and changing industry and the cost of providing health care
continues to increase, it is possible that the applicable state and federal
regulatory frameworks will expand to have a greater impact upon the conduct and
operation of the Company's business.


14
18

Under the current workers' compensation system, employer insurance or
self-funded coverage is governed by individual laws in each of the 50 states and
by certain federal laws. The management and information services that make up
the Company's managed care program serve markets that have developed largely in
response to needs of insurers, employers and large TPAs, and generally have not
been mandated by legislation or other government action. On the other hand, the
vocational rehabilitation case management marketplace within the workers'
compensation system has been dependent upon the laws and regulations within
those states that require the availability of specified rehabilitation services
for injured workers. Similarly, the Company's fee schedule auditing services
address market needs created by certain states' enactment of maximum permissible
fee schedules for workers' compensation services. Changes in individual state
regulation of workers' compensation may create a greater or lesser demand for
some or all of the Company's services, or require the Company to develop new or
modified services in order to meet the needs of the marketplace and compete
effectively in that marketplace.

Medical Cost Containment Legislation

Historically, governmental strategies to contain medical costs in the
workers' compensation field have been generally limited to legislation on a
state-by-state basis. For example, many states have implemented fee schedules
that list maximum reimbursement levels for health care procedures. In certain
states that have not authorized the use of a fee schedule, the Company adjusts
bills to the usual and customary levels authorized by the payor. Opportunities
for the Company's services could increase as more states legislate additional
cost containment strategies. Conversely, the Company could be adversely affected
if states elect to reduce the extent of medical cost containment strategies
available to insurance carriers and other payors, or adopt other strategies for
cost containment that would not support a demand for the Company's services.

Healthcare Reform

There has been considerable discussion of healthcare reform at both the
federal level and in numerous state legislatures in recent years. Due to
uncertainties regarding the ultimate features of reform initiatives and the
timing of their enactment, the Company cannot predict which, if any, reforms
will be adopted, when they may be adopted, or what impact they may have on the
Company.

Vocational Rehabilitation Legislation

During the early 1970s, the case management marketplace within workers'
compensation was dominated by the provision of medical management services. Such
services were purchased at the option of insurance carriers with little or no
support from legislative efforts within any of the states. By the mid-1970s, it
became popular for states to legislate either supportive programs for vocational
rehabilitation or, in some cases, mandatory vocational rehabilitation statutes.


15
19

SHAREHOLDER RIGHTS PLAN

During fiscal 1997, the Company's Board of Directors approved the
adoption of a Shareholder Rights Plan. The Rights Plan, which is similar to
rights plans adopted by numerous other public companies, provides for a dividend
distribution to CorVel stockholders of one preferred stock purchase "Right" for
each outstanding share of CorVel's Common Stock. The Rights are designed to
assure that all stockholders receive fair and equal treatment in the event of
any proposed takeover of the Company and to encourage a potential acquirer to
negotiate with the Board of Directors prior to attempting a takeover. The rights
have an exercise price of $62.50 per right, adjusted for the two-for-one stock
split paid on June 14, 1999, subject to subsequent adjustment. Initially, the
Rights will trade with the Company's common stock, and will not be exercisable
until the occurrence of certain takeover-related events.

Generally, the Rights Plan provides that if a person or group acquires
15% or more of the Company's Common Stock without the approval of the Board,
subject to certain exception, the holders of the rights, other than the
acquiring person or group, would, under certain circumstances, have the right to
purchase additional shares of the Company's Common Stock having a market value
equal to two times the then-current exercise price of the right.

In addition, if the Company is thereafter merged into another entity, or
if 50% or more of the Company's consolidated assets or earning power are sold,
then the Right will entitle its holder to buy common shares of the acquiring
entity having a market value equal to two times the then-current exercise price
of the Right. The Company's Board of Directors may exchange or redeem the Rights
under certain conditions.

EMPLOYEES

As of March 31, 2001, CorVel had approximately 3,000 employees,
including nurses, therapists, counselors and other employees. No employees are
represented by any collective bargaining unit. Management considers its
relationship with its employees to be good.

RISK FACTORS

Past financial performance is not necessarily a reliable indicator of
future performance, and investors in the Company's Common Stock should not use
historical performance to anticipate results or future period trends. The
Company's business and the market price of the Company's Common Stock are
subject to numerous risks and uncertainties. Some of those risks are described
below. Other risks are presented elsewhere in this Form 10-K. See, in
particular, "Management's Discussion and Analysis of Financial Condition and
Results of Operations".


16
20

POTENTIAL ADVERSE IMPACT OF GOVERNMENT REGULATION. Many states,
including a number of those in which the Company transacts business, have
licensing and other regulatory requirements applicable to the Company's
business. Approximately half of the states have enacted laws that require
licensing of businesses, which provide medical review services, such as the
Company. Some of these laws apply to medical review of care covered by workers'
compensation. These laws typically establish minimum standards for
qualifications of personnel, confidentiality, internal quality control and
dispute resolution procedures. These regulatory programs may result in increased
costs of operation for the Company, which may have an adverse impact upon the
Company's ability to compete with other available alternatives for health care
cost control. In addition, new laws regulating the operation of managed care
provider networks have been adopted by a number of states. These laws may apply
to managed care provider networks having contracts with the Company or to
provider networks, which the Company may organize. To the extent the Company is
governed by these regulations, it may be subject to additional licensing
requirements, financial and operational oversight and procedural standards for
beneficiaries and providers.

Regulation in the health care and workers' compensation fields is
constantly evolving. The Company is unable to predict what additional government
regulations, if any affecting its business may be promulgated in the future. The
Company's business may be adversely affected by failure to comply with existing
laws and regulations, failure to obtain necessary licenses and government
approvals or failure to adapt to new or modified regulatory requirements.
Proposals for health care legislative reforms are regularly considered at the
federal and state levels. To the extent that such proposals affect workers'
compensation, such proposals may adversely affect the Company's business and
results of operations.

In addition, changes in workers' compensation laws or regulations may
impact demand for the Company's services, require the Company to develop new or
modified services to meet the demands of the marketplace or modify the fees that
the Company may charge for its services. One of the proposals which has been
considered is 24-hour health coverage, in which the coverage of traditional
employer-sponsored health plans is combined with workers' compensation coverage
to provide a single insurance plan for work-related and non-work-related health
problems. Incorporating workers' compensation coverage into conventional health
plans may adversely affect the market for the Company's services.

POSSIBLE LITIGATION AND LEGAL LIABILITY. The Company, through its
utilization management services, makes recommendations concerning the
appropriateness of providers' medical treatment plans of patients throughout the
country, and as a result, could be exposed to claims for adverse medical
consequences. The Company does not grant or deny claims for payment of benefits
and the Company does not believe that it engages in the practice of medicine or
the delivery of medical services. There can be no assurance, however, that the
Company will not be subject to claims or litigation related to the grant or
denial of claims for payment of benefits or allegations that the Company engages
in the practice of medicine or the delivery of medical services.


17
21

In addition, there can be no assurance that the Company will not be
subject to other litigation that may adversely affect the Company's business or
results of operations. The Company maintains professional liability insurance
and such other coverages as the Company believes are reasonable in light of the
Company's experience to date. There can be no assurance; however, that such
insurance will be sufficient or available in the future at reasonable cost to
protect the Company from liability which might adversely affect the Company's
business or results of operations.

COMPETITION. The Company faces competition from HMOs, PPOs, TPAs and
other managed health care companies. The Company believes that, as managed care
techniques continue to gain acceptance in the workers' compensation marketplace,
CorVel's competitors will increasingly consist of nationally focused workers'
compensation managed care service companies, insurance companies, HMOs and other
significant providers of managed care products. Legislative reforms in some
states permit employers to designate health plans such as HMOs and PPOs to cover
workers' compensation claimants. Because many health plans have the ability to
manage medical costs for workers' compensation claimants, such legislation may
intensify competition in the markets served by the Company. Many of the
Company's current and potential competitors are significantly larger and have
greater financial and marketing resources than those of the Company, and there
can be no assurance that the Company will continue to maintain its existing
clients or its past level of operating performance or be successful with any new
products or in any new geographical markets it may enter.

CHANGES IN MARKET DYNAMICS. Within the past few years, several states
have experienced decreases in the number of workers' compensation claims and the
average cost per claim which have been reflected in workers' compensation
insurance premium rate reductions in those states. The Company believes that
declines in workers' compensation costs in these states are due principally to
intensified efforts by payors to manage and control claim costs, to improved
risk management by employers and to legislative reforms. If declines in workers'
compensation costs occur in many states and persist over the long-term, they may
have an adverse impact on the Company's business and results of operations.

DEPENDENCE UPON KEY PERSONNEL. The Company is dependent to a substantial
extent upon the continuing efforts and abilities of certain key management
personnel. In addition, the Company faces competition for experienced employees
with professional expertise in the workers' compensation managed care area. The
loss of, or the inability to attract, qualified employees could have a material
adverse effect on the Company's business and results of operations.

RISKS RELATED TO GROWTH STRATEGY. The Company's strategy is to continue
its internal growth and, as strategic opportunities arise in the workers'
compensation managed care industry, to consider acquisitions of, or
relationships with, other companies in related lines of business. As a result,
the Company is subject to certain growth-related


18
22

risks, including the risk that it will be unable to retain personnel or acquire
other resources necessary to service such growth adequately. Expenses arising
from the Company's efforts to increase its market penetration may have a
negative impact on operating results. In addition, there can be no assurance
that any suitable opportunities for strategic acquisitions or relationships will
arise or, if they do arise that the transactions contemplated thereby could be
completed. If such a transaction does occur, there can be no assurance that the
Company will be able to integrate effectively any acquired business into the
Company. In addition, any such transaction would be subject to various risks
associated with the acquisition of businesses, including the financial impact of
expenses associated with the integration of businesses.

There can be no assurance that any future acquisition or other strategic
relationship will not have an adverse impact on the Company's business or
results of operations. If suitable opportunities arise, the Company anticipates
that it would finance such transactions, as well as its internal growth, through
working capital or, in certain instances, through debt or equity financing.
There can be no assurance, however, that such debt or equity financing would be
available to the Company on acceptable terms when, and if, suitable strategic
opportunities arise.

During the past fiscal year, the Company has made efforts to increase
its presence and revenue in the group health market with moderate success.
Managed care in this market is maturer than managed care in workers'
compensation and has numerous large competitors, primarily HMOs. The Company has
limited experience in the group health market. There can be no assurance that
the Company will be successful in this market.

Certain aspects of the Company's business are dependent upon its ability
to store, retrieve, process and manage data and to maintain and upgrade its data
processing capabilities. Interruption of data processing capabilities for any
extended length of time, loss of stored data, programming errors or other
computer problems could have a material adverse effect on the Company's business
and results of operations. In addition, the company's results of operations are
highly dependent upon the ability of management to expeditiously retrieve and
analyze financial information from its nation-wide branch network. The company
is currently in the process of installing new company-wide management
information software and there can be no assurance that the installation of this
new system will proceed according to plan.

In addition, the Company expects that a considerable amount of its
future growth will depend on its ability to process and manage claims data more
efficiently and to provide more meaningful healthcare information to customers
and payors of healthcare. There can be no assurance that the Company's current
data processing capabilities will be adequate for its future growth, that it
will be able to efficiently upgrade its systems to meet future demands, or that
the Company will be able to develop, license or otherwise acquire software to
address these market demands as well or as timely as its competitors.

POSSIBLE VOLATILITY OF STOCK PRICE. The market price of the Company's
Common Stock may be highly volatile. Factors such as variations in the Company's
revenues, earnings and cash flow, general market trends in the workers'
compensation managed care


19
23

market, and announcements of innovations by the Company or its competitors could
cause the market price of the Common Stock to fluctuate substantially.
Specifically, the year-to-year percentage growth in operating results for the
Company's more recent fiscal years has been lower than the growth rates
historically experienced by the Company. The Company's slower growth rate in
those fiscal years was partially attributable to a reduction in the growth rate
of health care expenditures nationally, contributing to a reduction in the
growth of claims processed by the Company. There can be no assurance that the
Company's growth rate in the future, if any will be at or near historical
levels.

In addition, the stock market has in the past experienced price and
volume fluctuations that have particularly affected companies in the health care
and managed care markets resulting in changes in the market price of the stock
of many companies which may not have been directly related to the operating
performance of those companies.

IMPORTANCE OF INTELLECTUAL PROPERTY RIGHTS. The Company has made
significant investments in the development and maintenance of its proprietary
software systems and data. The Company relies largely on its own security
systems, confidentiality procedures and employee nondisclosure agreements to
maintain the confidentiality and security of its proprietary information.
Unauthorized access by third parties to the Company's information systems, the
existence of computer viruses in the Company's data or software and
misappropriation of the Company's proprietary information may have a material
adverse effect on the Company's business and results of operations.

ITEM 2. PROPERTIES.

The Company's principal executive office is located in Irvine,
California in approximately 3,500 square feet of leased space. The lease expires
in August 2002. The Company leases its branch offices, which range in size up to
approximately 11,000 square feet. The lease terms for the branch offices range
from monthly to seven years. The Company believes that its facilities are
adequate for its current needs and that suitable additional space will be
available as required.

ITEM 3. LEGAL PROCEEDINGS.

The Company is involved in litigation arising in the normal course of
business. The Company believes that resolution of these matters will not result
in any payment that, in the aggregate, would be material to the financial
position or financial operations of the Company.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

There were no matters submitted to a vote of stockholders during the
quarter ended March 31, 2001.


20
24

PART II

ITEM 5. MARKET FOR THE REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER
MATTERS.

MARKET INFORMATION

The Company's Common Stock is traded on the NASDAQ National Market under
the symbol CRVL. The quarterly high and low sales prices for the Company's
Common Stock for fiscal years 2000 and 2001 as reported by NASDAQ are set forth
below for the periods indicated as adjusted for the 2-for-1 stock split in the
form of a 100% dividend paid on June 14, 1999:

High Low
------ ------
FISCAL YEAR ENDED MARCH 31, 2000:
Quarter Ended June 30, 1999: $21.63 $17.50
Quarter Ended September 30, 1999: 26.25 20.25
Quarter Ended December 31, 1999: 24.00 16.94
Quarter Ended March 31, 2000: 29.00 21.38

FISCAL YEAR ENDED MARCH 31, 2001:
Quarter Ended June 30, 2000: $29.69 $22.75
Quarter Ended September 30, 2000: 29.50 25.05
Quarter Ended December 31, 2000: 37.88 25.50
Quarter Ended March 31, 2001: 37.25 31.50

The last sales price for the Company's Common Stock as reported by
NASDAQ on May 31, 2001 was $35.80. As of May 31, 2001, there were 750 holders of
record of the Company's Common Stock. The Company has never paid any cash
dividends on its Common Stock and has no current plans to do so.

ITEM 6. SELECTED FINANCIAL DATA.

The selected consolidated financial data of the Company appears in a
separate section of this Annual Report on Form 10-K on page 27.

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS.

Management's Discussion and Analysis of Financial Condition and Results
of Operations appears in a separate section of this Annual Report on Form 10-K
beginning on page 28.

ITEM 7a. QUANTITATIVE AND QUALITITATIVE DISCLOSURES ABOUT MARKET RISK.

Market risk generally represents the risk that losses may occur in the
values of financial instruments as a result of movements in interest rates,
foreign currency exchange rates and commodity prices. The Company has no market
risks in these areas.


21
25

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

The Company's consolidated financial statements and schedule, as listed
under Item 14, appear in a separate section of this Annual Report on Form 10-K
beginning on page 31 and 23, respectively.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE.

During fiscal 2001, the Company changed its independent accountants from
Ernst & Young LLP to Grant Thornton LLP. There were no disagreements with Ernst
& Young LLP on any accounting, principles or practices, financial statement
disclosure, or auditing scope or procedures.

PART III

ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT.

The sections titled "Directors and Nominees," "Executive Officers of the
Company," and "Compliance with Section 16(a) of the Exchange Act" appearing in
the Company's Definitive Proxy Statement for the 2001 Annual Meeting of
Stockholders are incorporated herein by reference.

ITEM 11. EXECUTIVE COMPENSATION.

The section titled "Executive Compensation and Related Information",
except as stated therein, appearing in the Company's Definitive Proxy Statement
for the 2001 Annual Meeting of Stockholders is incorporated herein by reference.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.

The section titled "Principal Stockholders" appearing in the Company's
Definitive Proxy Statement for the 2001 Annual Meeting of Stockholders is
incorporated herein by reference.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.

The section titled "Certain Transactions" appearing in the Company's
Definitive Proxy Statement for the 2001 Annual Meeting of Stockholders is
incorporated herein by reference.


22
26

PART IV

ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K.

(a)(1) CONSOLIDATED FINANCIAL STATEMENTS:

The Company's consolidated financial statements appear in a separate
section of this Annual Report on Form 10-K beginning on the pages referenced
below:

Page
----

Report of Independent Certified Public Accountants 31

Consolidated Statements of Income for the Years Ended
March 31, 1999, 2000, and 2001 33

Consolidated Balance Sheets as of March 31, 2000 and 2001 34

Consolidated Statements of Stockholders' Equity for the Years
Ended March 31, 1999, 2000, and 2001 35

Consolidated Statements of Cash Flows for the Years Ended
March 31, 1999, 2000, and 2001 37

Notes to Consolidated Financial Statements 38

(2) FINANCIAL STATEMENT SCHEDULE:

The Company's consolidated financial statements, as listed under Item
14(a)(1), appears in a separate section of the Annual Report on Form 10-K
beginning on page 31. The Company's financial statement schedule is as follows:

Schedule II - Valuation and Qualifying Accounts

<TABLE>
<CAPTION>
Additions
Balance at Charged to
Beginning Costs and Balance at
of Year Expenses Deductions End of Year
---------- ---------- ----------- -----------
<S> <C> <C> <C> <C>
ALLOWANCE FOR DOUBTFUL ACCOUNTS:

Year Ended March 31, 1999: $2,082,000 $2,085,000 $(1,152,000) $3,015,000
Year Ended March 31, 2000: 3,015,000 2,901,000 (2,521,000) 3,395,000
Year Ended March 31, 2001: 3,395,000 2,584,000 (2,592,000) 3,387,000
</TABLE>


23
27

(3) EXHIBITS:
EXHIBITS

<TABLE>
<CAPTION>
EXHIBIT
NO. TITLE METHOD OF FILING
- ------- ----- ----------------
<S> <C> <C>
3.1 Certificate of Incorporation of the Incorporated herein by reference to Exhibit 3.1 to
Company the Company's Registration Statement on Form S-1
Registration No. 33-40629.

3.2 Bylaws of the Company Incorporated herein by reference to Exhibit 3.2 to
the Company's Registration Statement on Form S-1
Registration No. 33-40629.

10.1 Nonqualified Stock Option Agreement Incorporated herein by reference to Exhibit 10.6 to
between V. Gordon Clemons, the Company the Company's Registration Statement on Form S-1
and North Star together with all Registration No. 33-40629.
amendments and addendums thereto

10.2 Supplementary Agreement between Incorporated herein by reference to Exhibit 10.7 to
V. Gordon Clemons, the Company and the Company's Registration Statement on Form S-1
North Star Registration No. 33-40629.

10.3 Amendment to Supplementary Agreement Incorporated herein by reference to Exhibit 10.5
between Mr. Clemons, the Company and to the Company's Annual Report on Form 10-K for
North Star the fiscal year ended March 31, 1992.

10.4 Restated 1988 Executive Stock Option Incorporated herein by reference to Exhibit 10.6 to
Plan, as amended the Company's Annual Report on Form 10-K for the
fiscal year ended March 31, 1995.

10.5 Form of Notice of Grant of Stock Option Incorporated herein by reference to Exhibit 10.8 to
Under the Restated 1988 Executive Stock the Company's Annual Report on Form 10-K for the
Option Plan fiscal year ended March 31, 1994.

10.6 Form of Stock Option Agreement under the Incorporated herein by reference to Exhibit 10.8 to
Restated 1988 Executive Stock Option the Company's Annual Report on Form 10-K for the
Plan fiscal year ended March 31, 1994.
</TABLE>


24
28

EXHIBITS (CONTINUED)

<TABLE>
<CAPTION>
EXHIBIT
NO. TITLE METHOD OF FILING
- ------- ----- ----------------
<S> <C> <C>
10.7 Form of Notice of Exercise under the Incorporated herein by reference to Exhibit 10.9 to
Restated 1988 Executive Stock Option the Company's Annual Report on Form 10-K for the
Plan fiscal year ended March 31, 1994.

10.8 Employment Agreement of V. Gordon Incorporated herein by reference to Exhibit 10.12
Clemons to the Company's Registration Statement on Form S-1
Registration No. 33-40629.

10.9 Restated 1991 Employee Stock Purchase Incorporated herein by reference to Exhibit 10.11
Plan, as amended in the Company's Annual Report on Form 10-K for the
fiscal year ended March 31, 1995.

10.10 Fidelity Master Plan for Savings and Incorporated herein by reference to Exhibits 10.16
Investment, and amendments and 10.16A to the Company's Registration Statement
on Form S-1 Registration No. 33-40629.

10.11 Daniel Davis Severance Arrangement Incorporated herein by reference to the Company's
Annual Report on Form 10-K for the fiscal year
ended March 31, 1993.

10.15 Shareholder Rights Plan Incorporated herein by reference to the Company's
Form 8-K filed on February 28, 1997.

21.1 Subsidiaries of the Company Attached.

23.1 Consent of Independent Auditors Attached.

23.2 Consent of Independent Auditors Attached.
</TABLE>

(b) REPORTS ON FORM 8-K

The Company filed a report on Form 8-K on April 5, 2001 to change the
Company's independent auditors from Ernst & Young LLP to Grant Thornton LLP
beginning with the audit for the fiscal year ended March 31, 2001.


25
29

SIGNATURES

Pursuant to the requirements of Section 13 or 15 (d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.


CORVEL CORPORATION


Date: June 27, 2001 By: /s/ V. GORDON CLEMONS
----------------------------
V. Gordon Clemons
Chairman and President

Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of the
Registrant and in the capacities and on the dates indicated.

<TABLE>
<CAPTION>

SIGNATURE TITLE DATE
--------- ----- ----
<S> <C> <C>
/s/ V. Gordon Clemons Chairman and President June 27, 2001
- -----------------------------
V. Gordon Clemons


/s/ Richard J. Schweppe Chief Financial Officer and June 27, 2001
- ----------------------------- Accounting Officer
Richard J. Schweppe


/s/ Peter E. Flynn Director June 27, 2001
- -----------------------------
Peter E. Flynn


/s/ Steven J. Hamerslag Director June 27, 2001
- -----------------------------
Steven J. Hamerslag


/s/ Judd Jessup Director June 27, 2001
- -----------------------------
Judd Jessup


/s/ Jeffrey J. Michael Director June 27, 2001
- -----------------------------
Jeffrey J. Michael
</TABLE>


26
30

SELECTED CONSOLIDATED FINANCIAL DATA

The following selected financial data for the five years ended March 31,
2001, have been derived from the Company's audited consolidated financial
statements. The following data should be read in conjunction with the Company's
Consolidated Financial Statements, the related notes thereto, and "Management's
Discussion and Analysis of Financial Condition and Results of Operations." The
following amounts are in thousands, except per share data.

<TABLE>
<CAPTION>
YEAR ENDED MARCH 31,
----------------------------------------------------------------
1997 1998 1999 2000 2001
-------- -------- -------- -------- --------
<S> <C> <C> <C> <C> <C>
STATEMENT OF INCOME DATA:
Revenues $121,704 $141,709 $165,457 $186,765 $209,554
Costs and Expenses:
Cost of revenues 99,323 115,553 136,082 152,710 172,010
General and administrative 8,645 11,029 12,596 14,752 16,389
-------- -------- -------- -------- --------
107,968 126,582 148,678 167,462 188,399
-------- -------- -------- -------- --------

Income before income taxes 13,736 15,127 16,779 19,303 21,155
Income tax provision 5,220 5,670 6,376 7,336 7,933
======== ======== ======== ======== ========
Net income $ 8,516 $ 9,457 $ 10,403 $ 11,967 $ 13,222
======== ======== ======== ======== ========
Net income per share:
Basic $ 0.93 $ 1.13 $ 1.28 $ 1.49 $ 1.74
======== ======== ======== ======== ========
Diluted $ 0.91 $ 1.10 $ 1.26 $ 1.47 $ 1.70
======== ======== ======== ======== ========
Shares used in computing net income
per share:
Basic 9,170 8,386 8,155 8,021 7,599
Diluted 9,370 8,572 8,261 8,151 7,781

Return on beginning of year equity 18.8% 20.5% 22.7% 22.5% 23.9%
Return on beginning of year assets 15.8% 16.1% 17.2% 17.4% 18.6%

<CAPTION>
BALANCE SHEET DATA AS OF MARCH 31, 1997 1998 1999 2000 2001
-------- -------- -------- -------- --------
<S> <C> <C> <C> <C> <C>
Cash and cash equivalents $ 15,665 $ 8,430 $ 9,052 $ 5,643 $ 9,457
Accounts receivable, net 22,294 25,633 31,562 35,874 34,316
Working capital 28,596 24,726 31,700 34,396 35,130
Total assets 58,824 60,491 68,737 71,187 77,565
Retained earnings 27,426 36,883 47,286 59,253 72,475
Treasury stock 9,461 21,727 26,990 39,956 53,903
Total stockholders' equity 46,087 45,771 53,214 55,293 58,718
</TABLE>


27
31

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Management's Discussion and Analysis of Financial Condition and
Results of Operations may include certain forward-looking statements, within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, including (without
limitation) statements with respect to anticipated future operating and
financial performance, growth and acquisition opportunities and other similar
forecasts and statements of expectation. Words such as "expects," "anticipates,"
"intends," "plans," "believes," "seeks," "estimates" and "should" and variations
of these words and similar expressions, are intended to identify these forward-
looking statements. Forward-looking statements made by the Company and its
management are based on estimates, projections, beliefs and assumptions of
management at the time of such statements and are not guarantees of future
performance.

The Company disclaims any obligations to update or revise any
forward-looking statement based on the occurrence of future events, the receipt
of new information or otherwise. Actual future performance, outcomes and results
may differ materially from those expressed in forward-looking statements made by
the Company and its management as a result of a number of risks, uncertainties
and assumptions. Representative examples of these factors include (without
limitation) general industry and economic conditions; cost of capital and
capital requirements; competition from other managed care companies; the ability
to expand certain areas of the Company's business; shifts in customer demands;
the ability of the Company to produce market-competitive software; changes in
operating expenses including employee wages, benefits and medical inflation;
governmental and public policy changes; dependence on key personnel; possible
litigation and legal liability in the course of operations; and the continued
availability of financing in the amounts and at the terms necessary to support
the Company's future business.

The Company derives the majority of its revenues from providing patient
management and provider program services to payors of workers' compensation
benefits and health insurance benefits. Patient management services include
early intervention, utilization review, medical case management, vocational
rehabilitation, and independent medical examinations. Provider program revenues
include fee schedule auditing, hospital bill auditing, and preferred provider
referral services. The percentages of revenues attributable to patient
management and provider program services for the fiscal years ended March 31,
1999, 2000, and 2001 are as follows:

1999 2000 2001
----- ----- -----
Patient management services 58.5% 59.9% 59.3%
Provider program services 41.5% 40.1% 40.7%
----- ----- -----
100.0% 100.0% 100.0%
===== ===== =====


28
32

RESULTS OF OPERATIONS

The following table sets forth, for the periods indicated, the
percentage of revenues represented by certain items reflected in the Company's
consolidated statements of income. The Company's past operating results are not
necessarily indicative of future operating results.

YEAR ENDED MARCH 31,
---------------------------------
1999 2000 2001
----- ----- -----
Revenues 100.0% 100.0% 100.0%
Cost of revenues 82.3 81.8 82.1
Gross profit 17.7 18.2 17.9
General and administrative 7.6 7.9 7.8
Income before income taxes 10.1 10.3 10.1
Net income 6.3 6.4 6.3

Years Ended March 31, 1999, 2000 and 2001

Revenues for fiscal 2000 increased by 13% to $187 million from $165
million in fiscal 1999, an increase of $22 million. The majority of this growth
came from patient management services, which grew 15% from $97 million in fiscal
year 1999 to $112 million in fiscal 2000, primarily due to new national
contracts to provide patient management services along with an increase in
referrals from existing customers. Provider program services increased by $6
million from $69 million in fiscal 1999 to $75 million in fiscal 2000, an
increase of 9%.

Revenues for fiscal 2001 increased by 12% to $210 million from $187
million in fiscal 2000, an increase of $23 million. The majority of this growth
came from patient management services, which grew 11% from $112 million in
fiscal year 2000 to $124 million in fiscal 2001, primarily due to an increase in
referrals from existing customers. Provider program services increased by $10
million from $75 million in fiscal 2000 to $85 million in fiscal 2001, an
increase of 13%. This increase is primarily due to the increased volume of bills
processed along with continued growth in the Company's provider network.

The Company's cost of revenues consists primarily of salaries, salary
related taxes and benefits, rent, telephone, and costs related to the Company's
computer operations, including depreciation and amortization. Costs of revenues
increased from $136 million in fiscal 1999 and $153 million in fiscal 2000, to
$172 million in fiscal 2001, primarily due to the increases in revenues as noted
above.


29
33

Cost of services as a percentage of revenues was 82.3% during fiscal
1999 and 81.8% in fiscal 2000, and increased to 82.1% in fiscal 2001. During
fiscal 2001, the cost of revenue percentage increased due to improved margins in
the provider programs business offset by declining margins in the patient
management business due to the percentage increase in costs exceeding the
percentage increase in prices. Patient management services have a higher cost of
services percentage than that of provider programs. There is no guarantee the
cost of service percentage will remain constant or decrease, should the Company
pursue a strategy of reducing price in order to obtain greater market share or
if competition causes pricing pressure in the industry.

General and administrative expense increased from $13 million in fiscal
1999 and $15 million in fiscal 2000 to $16 million in fiscal 2001. This increase
was primarily due to increased MIS staff to support the Company's implementation
of CareMC and further electronic data interface capabilities as required by
customer needs. General and administrative expenses were 7.6%, 7.9%, and 7.8%
for the years ended March 31, 1999, 2000 and 2001, respectively.

LIQUIDITY AND CAPITAL RESOURCES

The Company has funded its operations and capital expenditures primarily
from cash flow from operations. During fiscal 2000, net working capital
increased by $1 million from $34 million at March 31, 2000 to $35 million at
March 31, 2001. This increase is primarily due to the $13 million of net income
earned by the Company during fiscal 2001 offset by repurchase of the Company's
common stock. As of March 31, 2001, the Company had $9 million in cash and cash
equivalents, invested primarily in short-term, highly liquid investments with
maturities of 90 days or less. The Company has no interest-bearing short-term
debt.

The Company has historically required substantial capital to fund the
growth of its operations, particularly working capital to fund the growth in
accounts receivable and capital expenditures. The Company believes, however,
that the cash balance at March 31, 2001 along with anticipated internally
generated funds will be sufficient to meet the Company's expected cash
requirements for at least the next twelve months.


30
34

REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

Stockholders and Board of Directors
CorVel Corporation

We have audited the accompanying consolidated balance sheet of CorVel
Corporation as of March 31, 2001, and the related consolidated statements of
income, stockholders' equity, and cash flows for the year then ended. These
financial statements and schedule are the responsibility of the Company's
management. Our responsibility is to express an opinion on these financial
statements and schedule based on our audit.

We conducted our audit in accordance with auditing standards generally
accepted in the United States of America. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audit provides a
reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the consolidated financial position of
CorVel Corporation at March 31, 2001, and the consolidated results of its
operations and its cash flows for the year then ended, in conformity with
accounting principles generally accepted in the United States of America.

We have also audited Schedule II of CorVel Corporation for the year
ended March 31, 2001. In our opinion, this schedule presents fairly, in all
material respects, the information required to be set forth therein.


/s/ Grant Thornton LLP


Portland, Oregon
May 11, 2001


31
35

REPORT OF INDEPENDENT AUDITORS

Stockholders and Board of Directors
CorVel Corporation

We have audited the accompanying consolidated balance sheet of CorVel
Corporation as of March 31, 2000, and the related consolidated statements of
income, stockholders' equity, and cash flows for each of the two years in the
period ended March 31, 2000. Our audits also included the financial statement
schedule listed in the Index at Item 14(a). These financial statements and
schedule are the responsibility of the Company's management. Our responsibility
is to express an opinion on these financial statements and schedule based on our
audits.

We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the consolidated financial position of
CorVel Corporation at March 31, 2000, and the consolidated results of its
operations and its cash flows for each of the two years in the period ended
March 31, 2000, in conformity with generally accepted accounting principles.
Also, in our opinion, the related financial statement schedule, when considered
in relation to the basic financial statements taken as a whole, presents fairly
in all material respects the information set forth therein.


/s/ ERNST & YOUNG LLP


Orange County, California
May 9, 2000


32
36

CORVEL CORPORATION

CONSOLIDATED STATEMENTS OF INCOME

<TABLE>
<CAPTION>
YEARS ENDED MARCH 31,
----------------------------------------------
1999 2000 2001
------------ ------------ ------------
<S> <C> <C> <C>
REVENUES $165,457,000 $186,765,000 $209,554,000

COSTS AND EXPENSES
Cost of revenues 136,082,000 152,710,000 172,010,000
General and administrative 12,596,000 14,752,000 16,389,000
------------ ------------ ------------
148,678,000 167,462,000 188,399,000
------------ ------------ ------------
Income before income taxes 16,779,000 19,303,000 21,155,000
Income tax provision 6,376,000 7,336,000 7,933,000
------------ ------------ ------------
NET INCOME $ 10,403,000 $ 11,967,000 $ 13,222,000
============ ============ ============

Net income per share:
Basic $ 1.28 $ 1.49 $ 1.74
============ ============ ============
Diluted $ 1.26 $ 1.47 $ 1.70
============ ============ ============

Shares used in computing net income per share:
Basic 8,155,000 8,021,000 7,599,000
Diluted 8,261,000 8,151,000 7,781,000
</TABLE>

See accompanying notes to consolidated financial statements.


33
37

CORVEL CORPORATION
CONSOLIDATED BALANCE SHEETS

<TABLE>
<CAPTION>
MARCH 31,
------------------------------
2000 2001
------------ ------------
<S> <C> <C>
ASSETS

Current Assets
Cash and cash equivalents $ 5,643,000 $ 9,457,000
Accounts receivable (less allowance for
doubtful accounts of $3,395,000 in 2000
and $3,387,000 in 2001) 35,874,000 34,316,000
Prepaid expenses and taxes 1,931,000 2,465,000
Deferred income taxes 3,833,000 4,130,000
------------ ------------
Total current assets 47,281,000 50,368,000
------------ ------------

Property and equipment, net 16,631,000 20,071,000

Other assets 7,275,000 7,126,000
------------ ------------
$ 71,187,000 $ 77,565,000
============ ============

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities
Accounts and taxes payable $ 5,310,000 $ 3,006,000
Accrued liabilities 7,575,000 12,232,000
------------ ------------
Total current liabilities 12,885,000 15,238,000
------------ ------------

Deferred income taxes 3,009,000 3,609,000

Commitments and Contingencies

Stockholders' Equity

Common Stock, $.0001 par value: 20,000,000
shares authorized; 10,079,001 and 10,296,469
shares issued and outstanding in 2000 and
2001, respectively
1,000 1,000
Paid-in Capital
35,995,000 40,145,000
Treasury Stock, at cost (2,333,340 shares in
2000 and 2,807,940 shares in 2001)
(39,956,000) (53,903,000)
Retained Earnings
Total stockholders' equity 59,253,000 72,475,000
------------ ------------
55,293,000 58,718,000
------------ ------------
$ 71,187,000 $ 77,565,000
============ ============
</TABLE>

See accompanying notes to consolidated financial statements


34
38

CORVEL CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
YEARS ENDED MARCH 31, 1999, 2000, AND 2001

<TABLE>
<CAPTION>
COMMON
COMMON COMMON STOCK AND
STOCK- STOCK- PAID IN TREASURY
SHARES AMOUNT CAPITAL SHARES
---------- ---------- ----------- ----------
<S> <C> <C> <C> <C>
Balance - March 31, 1998 9,706,944 $ 1,000 $30,614,000 (1,461,200)
Stock issued under employee stock
purchase plan 34,428 -- 541,000 --
Stock issued and income tax
benefits under stock option plan,
net of shares repurchased
144,204 -- 1,762,000 --
Purchase of common stock -- -- -- (286,080)

Net income -- -- -- --
---------- ---------- ----------- ----------
Balance - March 31, 1999 9,885,576 1,000 32,917,000 (1,747,280)
---------- ---------- ----------- ----------
Stock issued under employee stock
purchase plan 34,800 -- 588,000 --

Stock issued and income tax
benefits under stock option plan,
net of shares repurchased 158,625 -- 2,490,000 --


Purchase of common stock -- -- -- (586,060)

Net income -- -- -- --
---------- ---------- ----------- ----------
Balance - March 31, 2000 10,079,001 1,000 35,995,000 (2,333,340)
---------- ---------- ----------- ----------
Stock issued under employee stock
purchase plan 30,072 -- 687,000 --

Stock issued and income tax
benefits under stock option plan,
net of shares repurchased 187,396 -- 3,463,000 --

Purchase of common stock -- -- -- (474,600)

Net income -- -- -- --
---------- ---------- ----------- ----------
Balance - March 31, 2001 10,296,469 $ 1,000 $40,145,000 (2,807,940)
========== ========== =========== ==========
</TABLE>

See accompanying notes to consolidated financial statements.


35
39

CORVEL CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - CONTINUED
YEARS ENDED MARCH 31, 1999, 2000, AND 2001

<TABLE>
<CAPTION>

SHARES - RETAINED TOTAL
COST EARNINGS SHAREHOLDERS'
------------ ----------- ------------
<S> <C> <C> <C>
Balance - March 31, 1998 $(21,727,000) $36,883,000 $ 45,771,000
Stock issued under employee stock purchase
plan -- -- 541,000

Stock issued and income tax benefits under
stock option plan, net of shares repurchased
-- -- 1,762,000

Purchase of common stock (5,263,000) -- (5,263,000)

Net income -- 10,403,000 10,403,000
------------ ----------- ------------
Balance - March 31, 1999 (26,990,000) 47,286,000 53,214,000
------------ ----------- ------------
Stock issued under employee stock purchase
plan -- -- 588,000

Stock issued and income tax benefits under
stock option plan -- -- 2,490,000

Purchase of common stock (12,966,000) -- (12,966,000)

Net income -- 11,967,000 11,967,000
------------ ----------- ------------
Balance - March 31, 2000 (39,956,000) 59,253,000 55,293,000
------------ ----------- ------------
Stock issued under employee stock purchase
plan -- -- 687,000

Stock issued and income tax benefits under
stock option plan, net of shares repurchased
-- -- 3,463,000

Purchase of common stock (13,947,000) -- (13,947,000)

Net income -- 13,222,000 13,222,000
------------ ----------- ------------
Balance - March 31, 2001 $(53,903,000) $72,475,000 $ 58,718,000
============ =========== ============
</TABLE>

See accompanying notes to consolidated financial statements.


36
40

CORVEL CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

<TABLE>
<CAPTION>
Years Ended March 31,
------------------------------------------------------
1999 2000 2001
------------ ------------ ------------
<S> <C> <C> <C>
CASH FLOWS FROM OPERATING ACTIVITIES
Net income $ 10,403,000 $ 11,967,000 $ 13,222,000

Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation 6,344,000 6,965,000 6,759,000
Deferred income taxes (588,000) (131,000) 303,000
Loss on write down and (gain) on disposal
of property and equipment 37,000 192,000 (45,000)
Changes in operating assets and liabilities:
Accounts receivable (5,929,000) (4,312,000) 1,558,000
Prepaid expenses and taxes (120,000) (1,075,000) (534,000)
Accounts and taxes payable 390,000 (1,158,000) (2,304,000)
Accrued liabilities 154,000 1,050,000 4,657,000
Other assets (482,000) (779,000) 149,000
------------ ------------ ------------
Net cash provided by operating activities 10,209,000 12,719,000 23,765,000
------------ ------------ ------------

CASH FLOWS FROM INVESTING ACTIVITIES

Purchases of property and equipment (6,627,000) (6,240,000) (10,154,000)
------------ ------------ ------------
Net cash used in investing activities (6,627,000) (6,240,000) (10,154,000)
------------ ------------ ------------

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds and tax benefits from
exercise of stock options 2,303,000 3,078,000 4,150,000
Purchase of common stock (5,263,000) (12,966,000) (13,947,000)
------------ ------------ ------------
Net cash used in financing activities (2,960,000) (9,888,000) (9,797,000)
------------ ------------ ------------

Net increase (decrease) in cash and cash equivalents 622,000 (3,409,000) 3,814,000
Cash and cash equivalents at beginning of year 8,430,000 9,052,000 5,643,000
------------ ------------ ------------
CASH AND CASH EQUIVALENTS AT END OF YEAR $ 9,052,000 $ 5,643,000 $ 9,457,000
============ ============ ============
</TABLE>

See accompanying notes to consolidated financial statements.


37
41

CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2001


NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization: CorVel Corporation (CorVel or the Company) provides
services and programs nationwide that are designed to enable insurance carriers,
third party administrators and employers with self-insured programs to
administer, manage and control the cost of workers' compensation and other
healthcare benefits.

Basis of Presentation: The consolidated financial statements include the
accounts of CorVel and its subsidiaries. Significant intercompany accounts and
transactions have been eliminated in consolidation.

Use of Estimates: The preparation of financial statements in conforming
with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the amounts
reported in the accompanying financial statements. Actual results could differ
from those estimates.

Cash and Cash Equivalents: Cash and cash equivalents consists of
short-term highly-liquid investments with maturities of 90 days or less when
purchased. The carrying amounts of the Company's financial instruments
approximate their relative fair values at March 31, 2000 and 2001.

Revenue Recognition: The Company's revenues are recognized primarily as
services are rendered based on time and expenses incurred. A certain portion of
the Company's revenues are derived from fee schedule auditing which is based on
the number of provider charges audited and, to a limited extent, on a percentage
of savings achieved for the Company's clients. Accounts receivable includes
$2,486,000 and $3,749,000 of unbilled receivables at March 31, 2000 and 2001,
respectively. No one customer accounted for more than 10% of consolidated
revenues during the years ended March 31, 1999, 2000 and 2001.

Property and Equipment: Additions to property and equipment are recorded
at cost. Depreciation and amortization are provided using the straight-line and
accelerated methods over the estimated useful lives of the related assets which
range from three to seven years.

Long-Lived Assets: The carrying amount of all long-lived assets is
evaluated periodically to determine if adjustment to the depreciation and
amortization period or to the unamortized balance is warranted. Such evaluation
is based principally on the expected utilization of the long-lived assets and
the projected, undiscounted cash flows of the operations in which the long-lived
assets are deployed.


38
42

CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2001

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Other Assets: Other assets consists primarily of the excess of the
purchase price over the estimated fair value of the net assets of businesses
acquired (goodwill) and is being amortized using the straight-line method over
periods not exceeding 40 years. Goodwill amounted to $6,013,000 (net of
accumulated amortization of $1,736,000) at March 31, 2000 and $5,978,000 (net of
accumulated amortization of $1,672,000) at March 31, 2001.

Concentrations of Credit Risk: The Company performs periodic credit
evaluations of its customers' financial condition and does not require
collateral. No other single customer accounted for 10% of accounts receivable in
2000 or 2001. Receivables are generally due within 60 days. Credit losses
relating to customers in the workers' compensation insurance industry
consistently have been within management's expectations.

Income Taxes: The Company provides for income taxes under the liability
method. Deferred tax assets and liabilities are determined based on differences
between financial reporting and tax bases of assets and liabilities as measured
by the enacted tax rates which are expected to be in effect when these
differences reverse. Income tax expense is the tax payable for the period and
the change during the period in net deferred tax assets and liabilities.

Earnings Per Share: Earnings per common share-basic is based on the
weighted average number of common shares outstanding during the period. Earnings
per common shares-diluted is based on the weighted average number of common
shares and common share equivalents outstanding during the period. In
calculating earnings per share, earnings are the same for the basic and diluted
calculations. Weighted average shares outstanding increased for diluted earnings
due to the effect of stock options.

Stock Option Plans: The Company applies the disclosure-only provisions
of Statement of Financial Accounting Standards No. 123, "Accounting for
Stock-Based Compensation" (SFAS No. 123) and accordingly, is continuing to
account for its stock-based compensation plans under Accounting Principles Board
Opinion No. 25, "Accounting for Stock Issued to Employees" and related
interpretations.


39
43

CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2001

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

In 1998, the Financial Accounting Standards Board ("FASB") issued
Statement of Financial Accounting Standards No. 133 ("SFAS 133"), Accounting for
Derivative Instruments and Hedging Activities, which is effective for 2000. SFAS
133 will require the Company to record all derivatives on the balance sheet at
fair value. For derivatives that are hedges, changes in the fair value of
derivatives will be offset by the changes in the fair value of the hedged
assets, liabilities or firm commitments. The new standard, as amended by SFAS
137 and SFAS 138, is effective for fiscal years beginning after June 15, 2000.
The Company believes the impact of adopting this standard will not be material
to results of operations or equity.

NOTE B - PROPERTY AND EQUIPMENT

Property and equipment consists of the following at March 31:

<TABLE>
<CAPTION>
2000 2001
----------- -----------
<S> <C> <C>
Office equipment and computers $30,851,000 $27,560,000
Computer software 13,735,000 14,201,000
Leasehold improvements 1,460,000 1,731,000
----------- -----------
46,046,000 43,492,000

Less: accumulated depreciation and amortization 29,415,000 23,421,000
----------- -----------
$16,631,000 $20,071,000
=========== ===========
</TABLE>

NOTE C - ACCRUED LIABILITIES

Accrued liabilities consists of the following at March 31:

2000 2001
----------- -----------
Payroll and related benefits $ 4,495,000 $ 9,401,000
Self-insurance accruals 829,000 1,610,000
Other 2,251,000 1,221,000
----------- -----------
$ 7,575,000 $12,232,000
=========== ===========


40
44

CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENT
MARCH 31, 2001

NOTE D - INCOME TAXES

The income tax provision consists of the following for the three years
ended March 31:

1999 2000 2001
----------- ----------- ----------
Current - Federal $ 6,337,000 $ 6,745,000 $7,010,000
Current - State 627,000 722,000 620,000
----------- ----------- ----------
Subtotal 6,964,000 7,467,000 7,630,000
----------- ----------- ----------
Deferred - Federal (537,000) (118,000) 277,000
Deferred - State (51,000) (13,000) 26,000
----------- ----------- ----------
Subtotal (588,000) (131,000) 303,000
----------- ----------- ----------
$ 6,376,000 $ 7,336,000 $7,933,000
=========== =========== ==========

Income tax benefits associated with the exercise of stock options were
$289,000, $577,000 and $673,000 for fiscal 1999, 2000, and 2001, respectively.

The following is a reconciliation of the income tax provision from the
statutory federal income tax rate to the effective rate for the three years
ended March 31:

<TABLE>
<CAPTION>
1999 2000 2001
----------- ---------- -----------
<S> <C> <C> <C>
Income taxes at federal statutory rate $ 5,873,000 $6,756,000 $ 7,404,000
State income taxes, net of federal benefit 471,000 465,000 646,000
Goodwill amortization 45,000 115,000 47,000
Other (13,000) -- (164,000)
----------- ---------- -----------
$ 6,376,000 $7,336,000 $ 7,933,000
=========== ========== ===========
</TABLE>

Income taxes paid totaled $4,787,000, $9,307,000 and $7,570,000 for the
years ended March 31, 1999, 2000, and 2001, respectively.


41
45

CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2001

NOTE D - INCOME TAXES (CONTINUED)

Deferred taxes at March 31, 2000 and 2001 are:

2000 2001
----------- -----------
Deferred tax assets:
Accrued liabilities not currently deductible $ 2,432,000 $ 2,806,000
Allowance for doubtful accounts 1,207,000 1,321,000
Other 194,000 3,000
----------- -----------
Deferred assets 3,833,000 4,130,000

Deferred tax liabilities:
Excess of tax under book basis of fixed assets (2,619,000) (3,067,000)
Other (390,000) (542,000)
----------- -----------
Deferred liability (3,009,000) (3,609,000)
----------- -----------
Net deferred tax asset $ 824,000 $ 521,000
=========== ===========

NOTE E - STOCK OPTION PLANS

The Company has elected to follow Accounting Principles Board Opinion
No. 25, "Accounting for Stock Issued to Employees" (APB No. 25) and related
interpretations in accounting for its employee stock options because, as
discussed below, the alternative fair value accounting provided for under SFAS
No. 123 requires use of option valuation models that were not developed for use
in valuing employee stock options. Under APB No. 25, because the exercise price
of the Company's employee stock options equals the market price of the
underlying stock on the date of grant, no compensation expense is recognized.

Under the Company's Restated 1988 Executive Stock Option Plan, ("the
Plan") as amended, options for up to 3,470,000 shares of the Company's common
stock may be granted to key employees, nonemployee directors and consultants at
prices not less than 85% of the fair value of the stock at the date of grant as
determined by the Board. Options granted under the Plan may be either incentive
stock options or non-statutory stock options and are generally exercisable
beginning one year from the date of grant and vest monthly thereafter for three
years.


42
46

CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2001

NOTE E - STOCK OPTION PLANS (CONTINUED)

In addition to the Plan, the Company's President was issued an option to
purchase 1,500,000 shares of common stock at an exercise price of $.0001 per
share in January 1988. As of March 31, 2001, all of these options have vested
and have been exercised. Summarized information for all stock options for the
past three fiscal year follows:

<TABLE>
<CAPTION>
1999 2000 2001
-------- -------- --------
<S> <C> <C> <C>
Options outstanding at the
Beginning of the year 761,932 796,406 789,343
Options granted 219,100 175,500 193,700
Options exercised (149,554) (164,313) (187,396)
Options cancelled (35,072) (18,250) (58,984)
-------- -------- --------
Options outstanding at the end
of the year 796,406 789,343 736,663
======== ======== ========

During the year, weighted average price
of options:

Granted $ 18.09 $ 21.13 $ 28.54

Exercised $ 10.55 $ 12.41 $ 15.08

Cancelled $ 15.20 $ 17.52 $ 19.54

At the end of the year:
Price range of outstanding options $ 8.50- $ 8.50- $ 8.50-
$ 18.88 $ 23.63 $ 34.75
Weighted average price per share $ 15.13 $ 16.99 $ 20.30
Options available for future grants 625,598 468,348 334,579
Exercisable options 333,764 339,889 321,627
</TABLE>


43
47

CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2001

NOTE E - STOCK OPTION PLANS (CONTINUED)

The following table summarizes the status of stock options outstanding
and exercisable at March 31, 2001:

<TABLE>
<CAPTION>
Outstanding Exercisable
Weighted Options- Exercisable Options-
Average Weighted Options- Weighted
Number of Remaining Average Number of Average
Range of Outstanding Contractual Exercise Exercisable Exercise
Exercise Prices Options Life Price Options Price
--------------- ----------- ----------- ---------- ----------- -----------
<S> <C> <C> <C> <C> <C>
$ 8.50 - $15.50 175,720 2.92 years $13.59 127,781 $13.55
17.44 - 18.00 151,575 2.31 years 17.84 93,998 17.82
18.09 - 23.63 221,721 3.56 years 20.33 99,848 19.77
26.25 - 34.75 186,700 4.78 years 28.59 - -
------- ---------- ------ ------- ------
Total 735,716 3.39 years $20.09 321,627 $16.73
======= ========== ====== ======= ======
</TABLE>

The Company has adopted the disclosure-only provisions of SFAS No. 123.
Had compensation cost for the Company's stock option and stock purchase plans
been recorded consistent with the provisions of SFAS No. 123, net income, net
income per share-basic and net income per common share-diluted would have been
for the three fiscal years ending March 31:

1999 2000 2001
---------- ----------- -----------
Net income - adjusted $9,971,000 $11,406,000 $12,584,000
Net income per share - basic $1.22 $1.42 $1.66
Net income per share - diluted $1.21 $1.40 $1.62

The weighted average fair values at date of grant for options during
fiscal 1999, 2000, and 2001, were $6.28, $6.56, and $9.59, respectively.

The fair value of each plan is estimated on the date of grant using the
Black-Scholes option-pricing model. The following weighted average assumptions
were used for fiscal years ending March 31:

1999 2000 2001
---- ---- ----
Expected volatility .28 .37 .41
Risk free interest rate 5.7% 6.6% 4.8%

The assumptions for all three years reflect no dividend yield and a
weighted average option life of 4.7 years.


44
48

CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2001

NOTE E - STOCK OPTION PLANS (CONTINUED)

The Black-Scholes option valuation model was developed for use in
estimating the fair value of traded options, which have no vesting restrictions
and are fully transferable. In addition, option valuation models require the
input of highly subjecting assumptions including the expected stock price
volatility. Because the Company's employee stock options have characteristics
significantly different from those of traded options, and because changes in the
subjective input assumptions can materially affect the fair value estimate, in
management's opinion, the existing models do not necessarily provide a reliable
single measure of the fair value of its employee stock options.

NOTE F - EMPLOYEE STOCK PURCHASE PLAN

The Company maintains an Employee Stock Purchase Plan which allows
employees of the Company and its subsidiaries to purchase shares of common stock
on the last day of two six-month purchase periods (i.e. March 31 and September
30) at a purchase price which is 85% of the closing sale price of shares as
quoted on NASDAQ on the first or last day of such purchase period, whichever is
lower. Employees are allowed to participate up to 20% of their gross pay. A
maximum of 500,000 shares has been authorized for issuance under the plan, as
amended. As of March 31, 1999, 339,000 shares had been issued pursuant to the
plan. Summarized plan information is as follows:

1999 2000 2001
-------- -------- --------
Employee contributions $541,000 $588,000 $687,000
Shares acquired 34,428 34,800 30,072
Average purchase price $15.71 $16.90 $22.85

NOTE G - TREASURY STOCK

The Company's Board of Directors has approved a plan to repurchase up to
3,400,000 shares of the Company's outstanding common stock. Purchases may be
made from time to time depending on market conditions and other relevant
factors. The share repurchases for fiscal years ending March 31, 1999, 2000 and
2001 are as follows:

1999 2000 2001 Cumulative
----------- ----------- ----------- -----------
Shares repurchased 286,080 586,060 474,600 2,807,940
Cost $ 5,263,000 $12,966,000 $13,947,000 $53,903,000
Average price $18.40 $22.12 $29.38 $19.20


45
49

CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2001

NOTE G - TREASURY STOCK (CONTINUED)

The repurchased shares were recorded as treasury stock, at cost, and is
available for general corporate purposes. The repurchases were financed from
cash generated from operations.

NOTE H - COMMITMENTS AND CONTINGENCIES

The Company leases office facilities under noncancelable operating
leases. Future minimum rental commitments under operating leases at March 31,
2001 are $7,202,000 in fiscal 2002, $5,574,000 in fiscal 2003, $3,878,000 in
fiscal 2004, $2,757,000 in fiscal 2005, $1,802,000 in fiscal 2006, and $827,000
thereafter. Total rental expense of $6,100,000, $7,100,000, and $8,685,000 was
charged to operations for the years ended March 31, 1999, 2000, and 2001,
respectively.

The Company is involved in litigation arising in the normal course of
business. The Company believes that resolution of these matters will not result
in any payment that, in the aggregate, would be material to the financial
position and results of the operations of the Company.

NOTE I - SAVINGS PLAN

The Company maintains a retirement savings plan for its employees, which
is a qualified plan under Section 401(k) of the Internal Revenue Code. Full-time
employees that meet certain requirements are eligible to participate in the
plan. Contributions are made annually primarily at the discretion of the
Company's Board of Directors. Contributions of $155,000, $199,000, and $224,000,
were charged to operations for the years ended March 31, 1999, 2000 and 2001,
respectively.


46
50

CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2001

NOTE J - SHAREHOLDER RIGHTS PLAN

During fiscal 1997, the Company's Board of Directors approved the
adoption of a Shareholder Rights Plan. The Rights Plan, which is similar to
rights plans adopted by numerous other public companies, provides for a dividend
distribution to CorVel stockholders of one preferred stock purchase "Right" for
each outstanding share of CorVel's common stock. The Rights are designed to
assure that all stockholders receive fair and equal treatment in the event of
any proposed takeover of the company and to encourage a potential acquirer to
negotiate with the Board of Directors prior to attempting a takeover. The Rights
have an exercise price of $62.50 per Right, as adjusted for the 2-for-1 stock
split in the form of a 100% stock dividend, paid on June 14, 1999, and subject
to subsequent adjustment. Initially, the Rights will trade with the company's
common stock, and will not be exercisable until the occurrence of certain
takeover-related events. The issuance of the Rights has no dilutive effect on
the Company's earnings per share.

NOTE K - QUARTERLY RESULTS

The following is a summary of unaudited results of operations for the
two years ended March 31, 2000 and 2001:

<TABLE>
<CAPTION>
Net income Net income
FISCAL YEAR ENDED MARCH per basic per diluted
31, 2000: Gross Net common common
Revenues Margin Income share share
----------- ----------- ----------- ---------- -----------
<S> <C> <C> <C> <C> <C>
First Quarter $45,705,000 $ 8,251,000 $ 2,877,000 $.35 .35
Second Quarter 45,865,000 8,406,000 2,970,000 .37 .36
Third Quarter 46,269,000 8,487,000 3,013,000 .38 .38
Fourth Quarter 48,926,000 8,911,000 3,107,000 .40 .39

FISCAL YEAR ENDED MARCH
31, 2001:
First Quarter $50,557,000 9,328,000 $3,227,000 $.42 $.41
Second Quarter 51,658,000 9,347,000 3,272,000 .43 .42
Third Quarter 52,241,000 9,059,000 3,328,000 .44 .43
Fourth Quarter 55,098,000 9,810,000 3,395,000 .45 .44
</TABLE>


47
51

EXHIBIT INDEX

<TABLE>
<CAPTION>
EXHIBIT
NO. TITLE - METHOD OF FILING PAGE
- --- ------------------------ ----
<S> <C> <C>
3.1 Certificate of Incorporation of the Company - Incorporated herein
by reference to Exhibit 3.1 to the Company's Registration
Statement on Form S-1 Registration No. 33-40629.

3.2 Bylaws of the Company - Incorporated herein by reference to
Exhibit 3.2 to the Company's Registration Statement on Form S-1
Registration No. 33-40629.

10.1 Nonqualified Stock Option Agreement between V. Gordon Clemons,
the Company and North Star together with all amendments and
addendums thereto - Incorporated herein by reference to Exhibit
10.6 to the Company's Registration Statement on Form S-1
Registration No. 33-40629.

10.2 Supplementary Agreement between V. Gordon Clemons, the Company
and North Star - Incorporated herein by reference to Exhibit 10.7
to the Company's Registration Statement on Form S-1 Registration
No. 33-40629.

10.3 Amendment to Supplementary Agreement between Mr. Clemons, the
Company and North Star - Incorporated herein by reference to
Exhibit 10.5 to the Company's Annual Report on Form 10-K for the
fiscal year ended March 31, 1992.

10.4 Restated 1988 Executive Stock Option Plan, as amended -
Incorporated herein by reference to Exhibit 10.5 to the Company's
Annual Report on Form 10-K for the fiscal year ended March 31,
1995.

10.5 Form of Notice of Grant of Stock Option Under the Restated 1988
Executive Stock Option Plan - - Incorporated herein by reference
to the Company's Annual Report on Form 10-K for the fiscal year
ended March 31, 1994.

10.6 Form of Stock Option Agreement under the Restated 1988 Executive
Stock Option Plan - Incorporated herein by reference to the
Company's Annual Report on Form 10-K for the fiscal year ended
March 31, 1994.
</TABLE>
52

EXHIBIT INDEX (CONTINUED)

<TABLE>
<CAPTION>
EXHIBIT
NO. TITLE - METHOD OF FILING PAGE
- --- ------------------------ ----
<S> <C> <C>

10.7 Form of Notice of Exercise under the Restated 1988 Executive
Stock Option Plan - Incorporated herein by reference to the
Company's Annual Report on Form 10-K for the fiscal year ended
March 31, 1994.

10.8 Employment Agreement of V. Gordon Clemons - Incorporated herein
by reference to Exhibit 10.12 to the Company's Registration
Statement on Form S-1 Registration No. 33-40629.

10.9 Restated 1991 Employee Stock Purchase Plan, as amended -
Incorporated herein by reference to Exhibit 10.11 in the
Company's Annual Report on Form 10-K for the fiscal year ended
March 31, 1995.

10.10 Fidelity Master Plan for Savings and Investments, and amendments
- Incorporated herein by reference to Exhibit 10.16 and 10.16A to
the Company's Registration Statement on Form S-1 Registration No.
33-40629.

10.11 Daniel Davis Severance Arrangement - Incorporated herein by
reference to the Company's Annual Report on Form 10-K for the
fiscal year ended March 31, 1993.

10.12 Shareholder Rights Plan - Incorporated herein by reference to the
Company's 8-K filed on February 28, 1997.

21.1 Subsidiaries of the Company - Attached.

23.1 Consent of Independent Auditors - Attached.

23.2 Consent of Independent Auditors - Attached.
</TABLE>